Core Scientific (CORZ) Cash & Current Investments (2021 - 2026)

Core Scientific (CORZ) has 6 years of Cash & Current Investments data on file, last reported at $1.1 billion in Q1 2026.

• Quarterly Cash & Current Investments rose 52.49% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 52.49% YoY) and the FY2025 annual result came in at $311.4 million, down 62.8% from the prior year.
• Cash & Current Investments grew to $1.1 billion in Q1 2026 per CORZ's latest filing, from $311.4 million in the prior quarter.
• The five-year high for Cash & Current Investments was $1.1 billion in Q1 2026, with the low at $37.6 million in Q3 2022.
• Average Cash & Current Investments over 5 years is $311.6 million, with a median of $140.4 million recorded in 2022.
• Year-over-year, Cash & Current Investments surged 18181.06% in 2022 and sank 81.55% in 2023.
• Core Scientific's Cash & Current Investments stood at $52.2 million in 2022, then soared by 33.44% to $69.7 million in 2023, then surged by 1100.68% to $837.0 million in 2024, then tumbled by 62.8% to $311.4 million in 2025, then soared by 242.15% to $1.1 billion in 2026.
• Business Quant data shows CORZ's Cash & Current Investments at $1.1 billion in Q1 2026, $311.4 million in Q4 2025, and $453.4 million in Q3 2025.